NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)

NCT01654250 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG: NWP09
DRUG: Placebo

Sponsor

Pfizer